Calidi Biotherapeutics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q2 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Calidi Biotherapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q2 2021 to Q1 2024.
  • Calidi Biotherapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $3.01M, a 20.5% decline year-over-year.
  • Calidi Biotherapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $29M, a 140% increase from 2022.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.01M -$778K -20.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $3.79M +$3.79M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q2 2021 $214K Mar 24, 2021 Jun 30, 2021 10-Q 2022-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.